Search results
Nov 7, 2023 · CEO Anne Wojcicki on turning 23andMe into a ‘full-fledged biotech’. 23andMe always had larger aims than at-home genetics testing. In this in-depth interview, Wojcicki explains the company’s foray into drug R&D. Anne Wojcicki attends a 2019 event at the Wallis Annenberg Center for the Performing Arts in Los Angeles.
Apr 29, 2022 · Anne Wojcicki, Co-Founder of 23andMe: Making Her Own Way. Post grad, Wojcicki began working as a healthcare consultant at Passport Capital and at Investor AB. Passport Capital is an investment fund based in San Francisco. For four years, she worked as a healthcare investment analyst.
Oct 12, 2017 · There's a placard in Anne Wojcicki's office enshrining the attitude that nearly ran her company, 23andme, aground. Tucked behind a toy unicorn, the small, wood-veneered nameplate reads: “I'm CEO ...
Feb 12, 2024 · Science. Feb 12, 2024 9:57 AM. 23andMe Is Under Fire. Its Founder Remains ‘Optimistic’. 23andMe’s CEO Anne Wojcicki has saved the genetics company from the brink of failure before. She sat ...
Dec 2, 2021 · The deal left Wojcicki holding about 99 million publicly-traded shares worth $13.32 each by the end of their first day of trading—putting her stake at more than $1.3 billion.
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics.
Susan Diane Wojcicki ( / wʊˈtʃɪtski / woo-CHITS-kee; [1] born July 5, 1968) is an American business executive who was the chief executive officer (CEO) of YouTube from 2014 to 2023. Her net worth was estimated at $765 million in 2022. [2] Wojcicki has worked in the technology industry for over twenty years.
